Roivant Sciences Ltd Ordinary Shares ROIV 深 沪
已收盘 07-26 16:00:00 美东时间
10.80
+0.060
+0.56%
华盛通- 最 高11.07
- 今 开10.77
- 成交量 357.98万股
- 最 低 10.76
- 昨 收 10.74
- 总市值 76.03亿
- 52周最高 13.24
- 市盈率 静 2.06
- 换手率 0.51%
- 52周最低 8.245
- 委 比 40.12%
- 总股本 7.04亿
- 历史最高 16.76
- 量 比 1.04
- 振 幅 2.89%
- 历史最低 2.52
- 每 手 1
- 风险率 0.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Evaluating Roivant Sciences: Insights From 6 Financial Analysts
Roivant Sciences (NASDAQ:ROIV) has been analyzed by 6 analysts in the last thre...
06-18 23:00
Cantor Fitzgerald Reiterates Overweight on Roivant Sciences
Cantor Fitzgerald analyst Louise Chen reiterates Roivant Sciences (NASDAQ:ROIV) with a Overweight.
06-18 22:07
Roivant Sciences' (NASDAQ:ROIV) Performance Raises Some Questions
Even though Roivant Sciences Ltd. (NASDAQ:ROIV) posted strong earnings recently...
06-06 19:41
Roivant Sciences Ltd.2024财年实现净利润43.49亿美元，同比增加486.92%
5月31日，Roivant Sciences Ltd.（ROIV.US）公布财报，公告显示公司2024财年净利润为43.49亿美元，同比增加486.92%；其中...
05-31 23:09
HC Wainwright & Co.：重申Roivant Sciences(ROIV.US)评级，由买入调整至买入评级, 目标价由18.00美元调整至18.00美元。
HC Wainwright & Co.：重申Roivant Sciences(ROIV.US)评级，由买入调整至买入评级, 目标价由18.00美元调整至...
05-31 18:41
Vivek Ramaswamy Breathes New Life In Beaten Down BuzzFeed Stock: What's Going On?
BuzzFeed shares surged after Vivek Ramaswamy acquired a 7.7% stake for $3.2 million.
05-22 20:04
Arbutus Biopharma jumps after patent victory in fight with Moderna
Arbutus Biopharma (NASDAQ:ABUS) quickly soared 15% after a win in a Covid vaccine patent dispute with Moderna (NASDAQ:MRNA), according to a court filing on Wednesday. Moderna fell 0.5%. The patent dec...
04-04 00:27
Vivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage Study
Roivant Sciences and Priovant Therapeutics report Phase 2 results for brepocitinib in treating non-anterior non-infectious uveitis. Week 24 data show promising efficacy, with lower treatment failure rates and positive secondary endpoints. Roivant authorizes a $1.5 billion share repurchase program
04-03 00:31
Roivant announces $1.5B share buyback, positive Phase 2 data
Shares of Roivant (NASDAQ:ROIV) rose 6% in premarket trading Tuesday after the biotech group announced a $1.5B share buyback program and released positive data for its drug brepocitinib. Roivant’s boa...
04-02 21:20
XTIA, HUSA and GXAI are among premarket gainers
Gainers: XTI Aerospace (XTIA) +85%. Kidpik (PIK) +46% announce entry into a definitive merger agreement. Ashford (AINC) +61% BOARD OF DIRECTORS APPROVES PLAN TO TERMINATE REGISTRATION OF ITS COMMON...
04-02 20:25
